209 related articles for article (PubMed ID: 25873436)
1. Prognostic effect of comorbidity indices in elderly patients with multiple myeloma.
Bila J; Jelicic J; Djurasinovic V; Vukovic V; Sretenovic A; Andjelic B; Antic D; Todorovic M; Mihaljevic B
Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):416-9. PubMed ID: 25873436
[TBL] [Abstract][Full Text] [Related]
2. Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.
Engelhardt M; Dold SM; Ihorst G; Zober A; Möller M; Reinhardt H; Hieke S; Schumacher M; Wäsch R
Haematologica; 2016 Sep; 101(9):1110-9. PubMed ID: 27479825
[TBL] [Abstract][Full Text] [Related]
3. Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China.
Zhong YP; Zhang YZ; Liao AJ; Li SX; Tian C; Lu J
Chin Med J (Engl); 2017 Jan; 130(2):130-134. PubMed ID: 28091402
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Freiburg Comorbidity Index in 466 multiple myeloma patients and combination with the international staging system are highly predictive for outcome.
Kleber M; Ihorst G; Gross B; Koch B; Reinhardt H; Wäsch R; Engelhardt M
Clin Lymphoma Myeloma Leuk; 2013 Oct; 13(5):541-51. PubMed ID: 23810244
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Freiburg and Charlson comorbidity indices in predicting overall survival in elderly patients with newly diagnosed multiple myeloma.
Kim SM; Kim MJ; Jung HA; Kim K; Kim SJ; Jang JH; Kim WS; Jung CW
Biomed Res Int; 2014; 2014():437852. PubMed ID: 25114902
[TBL] [Abstract][Full Text] [Related]
6. Influence of cognitive impairment and comorbidity on disability in hospitalized elderly patients.
Orsitto G; Cascavilla L; Franceschi M; Aloia RM; Greco A; Paris F; Seripa D; Pilotto A
J Nutr Health Aging; 2005; 9(3):194-8. PubMed ID: 15864400
[TBL] [Abstract][Full Text] [Related]
7. Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry.
Offidani M; Corvatta L; Polloni C; Centurioni R; Visani G; Brunori M; Gentili S; Catarini M; Samori A; Blasi N; Alesiani F; Caraffa P; Burattini M; Galieni P; Fraticelli P; Ferranti M; Giuliodori L; Leoni P
Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):423-32. PubMed ID: 22981966
[TBL] [Abstract][Full Text] [Related]
8. Real-World Clinical Outcomes in Elderly Chinese Patients with Multiple Myeloma: A Single-Center Experience.
Qian X; Chen H; Xia J; Wang J; Zhou X; Guo H
Med Sci Monit; 2018 Aug; 24():5887-5893. PubMed ID: 30138301
[TBL] [Abstract][Full Text] [Related]
9. International prognostic index (IPI)--a critical comparison with five multiple myeloma staging systems in the group of 270 patients treated by conventional chemotherapy.
Scudla V; Zemanova M; Minarik J; Bacovsky J; Ordeltova M; Indrak K; Budikova M; Dusek L; Farbiakova V
Neoplasma; 2006; 53(4):277-84. PubMed ID: 16830053
[TBL] [Abstract][Full Text] [Related]
10. A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients.
Engelhardt M; Domm AS; Dold SM; Ihorst G; Reinhardt H; Zober A; Hieke S; Baayen C; Müller SJ; Einsele H; Sonneveld P; Landgren O; Schumacher M; Wäsch R
Haematologica; 2017 May; 102(5):910-921. PubMed ID: 28154088
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity, disability and geriatric syndromes in elderly breast cancer survivors. Results of a single-center experience.
Gironés R; Torregrosa D; Díaz-Beveridge R
Crit Rev Oncol Hematol; 2010 Mar; 73(3):236-45. PubMed ID: 19748793
[TBL] [Abstract][Full Text] [Related]
12. Outcome-specific Charlson Comorbidity Indices for Predicting Poor Inpatient Outcomes Following Noncardiac Surgery Using Hospital Administrative Data.
Moodley Y
Med Care; 2016 Dec; 54(12):1082-1088. PubMed ID: 27326550
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of the Charlson comorbidity index on mortality following acute pulmonary embolism.
Ng AC; Chow V; Yong AS; Chung T; Kritharides L
Respiration; 2013; 85(5):408-16. PubMed ID: 23147354
[TBL] [Abstract][Full Text] [Related]
14. The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR).
Bergin K; Wellard C; Moore E; McQuilten Z; Blacklock H; Harrison SJ; Ho PJ; King T; Quach H; Mollee P; Walker P; Wood E; Spencer A;
Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e510-e520. PubMed ID: 33785297
[TBL] [Abstract][Full Text] [Related]
15. How many and which items of activities of daily living (ADL) and instrumental activities of daily living (IADL) are necessary for screening.
Roehrig B; Hoeffken K; Pientka L; Wedding U
Crit Rev Oncol Hematol; 2007 May; 62(2):164-71. PubMed ID: 17169569
[TBL] [Abstract][Full Text] [Related]
16. [Clinical features and prognosis of 93 elderly patients with multiple myeloma].
Chen HM; Zhou F; Wei W; Peng R; Shi HT; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2017 Sep; 38(9):744-748. PubMed ID: 29081189
[No Abstract] [Full Text] [Related]
17. Association of the Charlson comorbidity index and hypertension with survival in men with metastatic castration-resistant prostate cancer.
Goyal J; Pond GR; Galsky MD; Hendricks R; Small A; Tsao CK; Sonpavde G
Urol Oncol; 2014 Jan; 32(1):36.e27-34. PubMed ID: 23685020
[TBL] [Abstract][Full Text] [Related]
18. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
[TBL] [Abstract][Full Text] [Related]
19. Prognostic risk factor evaluation in patients with relapsed or refractory multiple myeloma receiving lenalidomide treatment: analysis of renal function by eGFR and of additional comorbidities by comorbidity appraisal.
Kleber M; Ihorst G; Udi J; Koch B; Wäsch R; Engelhardt M
Clin Lymphoma Myeloma Leuk; 2012 Feb; 12(1):38-48. PubMed ID: 22054851
[TBL] [Abstract][Full Text] [Related]
20. The application of the Palliative Prognostic Index, charlson comorbidity index, and Glasgow Prognostic Score in predicting the life expectancy of patients with hematologic malignancies under palliative care.
Chou WC; Kao CY; Wang PN; Chang H; Wang HM; Chang PH; Yeh KY; Hung YS
BMC Palliat Care; 2015 Apr; 14():18. PubMed ID: 25924723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
